News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,575 Results
Type
Article (88194)
Company Profile (823)
Press Release (784537)
Multimedia
Podcasts (208)
Webinars (32)
Section
Business (233353)
Career Advice (4152)
Deals (39897)
Drug Delivery (157)
Drug Development (91480)
Employer Resources (205)
FDA (18439)
Job Trends (17442)
News (398139)
Policy (39997)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3024)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (165)
Alliances (56982)
ALS (191)
Alzheimer's disease (1826)
Antibody-drug conjugate (ADC) (379)
Approvals (18640)
Artificial intelligence (685)
Autoimmune disease (201)
Automation (48)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (176)
Brain cancer (69)
Breast cancer (696)
Cancer (5361)
Cardiovascular disease (475)
Career advice (3580)
Career pathing (44)
CAR-T (318)
CDC (68)
Celiac Disease (2)
Cell therapy (877)
Cervical cancer (41)
Clinical research (77437)
Collaboration (1967)
Company closure (6)
Compensation (1243)
Complete response letters (82)
COVID-19 (3005)
CRISPR (110)
C-suite (972)
Cystic fibrosis (157)
Data (6711)
Decentralized trials (2)
Denatured (77)
Depression (163)
Diabetes (556)
Diagnostics (7332)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (332)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (258)
Earnings (100778)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135914)
Executive appointments (1074)
FDA (21819)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (26)
Funding (1653)
Gene editing (234)
Generative AI (71)
Gene therapy (722)
GLP-1 (1170)
Government (5484)
Grass and pollen (8)
Guidances (389)
Healthcare (20984)
HIV (76)
Huntington's disease (54)
IgA nephropathy (90)
Immunology and inflammation (312)
Immuno-oncology (76)
Indications (134)
Infectious disease (3323)
Inflammatory bowel disease (219)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17971)
IRA (61)
Job creations (5202)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (100)
Layoffs (664)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (22)
Lung cancer (717)
Lymphoma (397)
Machine learning (49)
Management (66)
Manufacturing (930)
MASH (184)
Medical device (15098)
Medtech (15164)
Mergers & acquisitions (23046)
Metabolic disorders (1484)
mRNA (201)
Multiple sclerosis (179)
NASH (23)
Neurodegenerative disease (386)
Neuropsychiatric disorders (108)
Neuroscience (3252)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5124)
Now hiring (70)
Obesity (725)
Opinion (349)
Ovarian cancer (176)
Pain (233)
Pancreatic cancer (254)
Parkinson's disease (317)
Partnered (39)
Patents (548)
Patient recruitment (556)
Peanut (65)
People (67172)
Pharmaceutical (144)
Pharmacy benefit managers (34)
Phase 1 (23926)
Phase 2 (33599)
Phase 3 (25316)
Pipeline (6160)
Policy (359)
Postmarket research (3554)
Preclinical (10728)
Press Release (72)
Prostate cancer (273)
Psychedelics (60)
Radiopharmaceuticals (318)
Rare diseases (1024)
Real estate (7445)
Recruiting (81)
Regulatory (29369)
Reports (69)
Research institute (2746)
Resumes & cover letters (653)
Rett syndrome (31)
RNA editing (21)
RSV (90)
Schizophrenia (166)
Series A (278)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4340)
State (2)
Stomach cancer (21)
Supply chain (120)
Tariffs (101)
The Weekly (129)
Vaccines (1193)
Venture capital (103)
Weight loss (496)
Women's health (106)
Worklife (23)
Date
Today (143)
Last 7 days (831)
Last 30 days (3307)
Last 365 days (32790)
2026 (5891)
2025 (33228)
2024 (38138)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (355)
Arkansas (15)
Asia (51705)
Australia (9085)
California (12246)
Canada (3482)
China (1235)
Colorado (517)
Connecticut (534)
Delaware (363)
Europe (118988)
Florida (1817)
Georgia (397)
Hawaii (4)
Idaho (68)
Illinois (1025)
India (81)
Indiana (574)
Iowa (24)
Japan (471)
Kansas (135)
Kentucky (49)
Louisiana (37)
Maine (85)
Maryland (1521)
Massachusetts (8992)
Michigan (381)
Minnesota (692)
Mississippi (7)
Missouri (146)
Montana (36)
Nebraska (30)
Nevada (134)
New Hampshire (88)
New Jersey (3287)
New Mexico (33)
New York (3223)
North Carolina (1689)
North Dakota (10)
Northern California (5922)
Ohio (377)
Oklahoma (23)
Oregon (55)
Pennsylvania (2438)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4749)
Tennessee (193)
Texas (1928)
United States (44061)
Utah (370)
Vermont (1)
Virginia (308)
Washington D.C. (88)
Washington State (1013)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
There are 873,575 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.
March 5, 2026
·
5 min read
Press Releases
Cantargia to Participate at Van Lanschot Kempen’s Life Sciences Conference
March 5, 2026
·
1 min read
Press Releases
Oculis Publishes 2025 Consolidated Financial Statements
March 5, 2026
·
1 min read
Press Releases
Oculis to Participate in Upcoming March 2026 Investor Conferences
March 5, 2026
·
4 min read
Press Releases
Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals
March 5, 2026
·
2 min read
Press Releases
Press Release: Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director
March 5, 2026
·
3 min read
Press Releases
Vicore Pharma Elevates Leadership Team Ahead of Key Clinical and Corporate Milestones
March 5, 2026
·
3 min read
Press Releases
Swarm Oncology appoints Bernhard Ehmer as Chairman
March 5, 2026
·
3 min read
Insights
From Grants to Family Offices: Building a Unified Financing Strategy in Biotech
In this episode of Denatured, you’ll listen to Ram May-Ron, managing partner at FreeMind Group, and Ravi Kiron, managing director at Biopharma Strategy Advisors. We’ll be speaking about how to combine nondilutive funding and family office money into a unified strategy that gets companies through the drug development valley of death.
March 5, 2026
·
1 min read
·
Jennifer Smith-Parker
Job Trends
Keeping the Door Open: Many Would Return to Companies That Laid Them Off
Over half of biopharma professionals would work again at the companies that let them go, according to a
BioSpace
LinkedIn poll. Several professionals, as well as recruiting and talent acquisition experts, discuss reasons for—and a key risk of—going back.
March 5, 2026
·
5 min read
·
Angela Gabriel
1 of 87,358
Next
